KIR3DL2: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
m (Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}}))
 
m (Bot: HTTP→HTTPS)
Line 1: Line 1:
<!-- The PBB_Controls template provides controls for Protein Box Bot, please see Template:PBB_Controls for details. -->
{{Infobox_gene}}
{{PBB_Controls
'''Killer cell immunoglobulin-like receptor 3DL2''' is a [[protein]] that in humans is encoded by the ''KIR3DL2'' [[gene]].<ref name="pmid7716543">{{cite journal |vauthors=Colonna M, Samaridis J | title = Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells | journal = Science | volume = 268 | issue = 5209 | pages = 405–8 |date=May 1995 | pmid = 7716543 | pmc =  | doi =10.1126/science.7716543 }}</ref><ref name="pmid8662091">{{cite journal |vauthors=Dohring C, Samaridis J, Colonna M | title = Alternatively spliced forms of human killer inhibitory receptors | journal = Immunogenetics | volume = 44 | issue = 3 | pages = 227–30 |date=Aug 1996 | pmid = 8662091 | pmc =  | doi =10.1007/BF02602590 }}</ref><ref name="entrez">{{cite web | title = Entrez Gene: KIR3DL2 killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=3812| accessdate = }}</ref>
| update_page = yes
| require_manual_inspection = no
| update_protein_box = yes
| update_summary = yes
| update_citations = yes
}}
<!-- The GNF_Protein_box is automatically maintained by Protein Box Bot. See Template:PBB_Controls to Stop updates. -->
{{GNF_Protein_box
| image =
| image_source = 
| PDB =  
| Name = Killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2
| HGNCid = 6339
| Symbol = KIR3DL2
| AltSymbols =; CD158K; CL-5; MGC125321; NKAT4; NKAT4A; NKAT4B
| OMIM = 604947
| ECnumber =
| Homologene = 88746
| MGIid =
| Function = {{GNF_GO|id=GO:0004872 |text = receptor activity}}
  | Component = {{GNF_GO|id=GO:0005887 |text = integral to plasma membrane}} {{GNF_GO|id=GO:0016020 |text = membrane}}
  | Process = {{GNF_GO|id=GO:0006968 |text = cellular defense response}}  
| Orthologs = {{GNF_Ortholog_box
    | Hs_EntrezGene = 3812
    | Hs_Ensembl =
    | Hs_RefseqProtein = NP_006728
    | Hs_RefseqmRNA = NM_006737
    | Hs_GenLoc_db =
    | Hs_GenLoc_chr =
    | Hs_GenLoc_start =
    | Hs_GenLoc_end =
    | Hs_Uniprot =
    | Mm_EntrezGene =
    | Mm_Ensembl =   
    | Mm_RefseqmRNA = 
    | Mm_RefseqProtein = 
    | Mm_GenLoc_db = 
    | Mm_GenLoc_chr =   
    | Mm_GenLoc_start = 
    | Mm_GenLoc_end = 
    | Mm_Uniprot = 
  }}
}}
'''Killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2''', also known as '''KIR3DL2''', is a human [[gene]].<ref name="entrez">{{cite web | title = Entrez Gene: KIR3DL2 killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=3812| accessdate = }}</ref>
<!-- The PBB_Summary template is automatically maintained by Protein Box Bot.  See Template:PBB_Controls to Stop updates. -->
<!-- The PBB_Summary template is automatically maintained by Protein Box Bot.  See Template:PBB_Controls to Stop updates. -->
{{PBB_Summary
{{PBB_Summary
| section_title =  
| section_title =  
| summary_text = Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several &quot;framework&quot; genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. This gene is one of the &quot;framework&quot; loci that is present on all haplotypes.<ref name="entrez">{{cite web | title = Entrez Gene: KIR3DL2 killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=3812| accessdate = }}</ref>
| summary_text = [[Killer cell immunoglobulin-like receptors]] (KIRs) are [[Transmembrane protein|transmembrane]] glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb [[leukocyte receptor complex]] (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several &quot;framework&quot; genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. This gene is one of the &quot;framework&quot; loci that is present on all haplotypes.<ref name="entrez" />
}}
}}


Line 55: Line 11:


==References==
==References==
{{reflist|2}}
{{reflist}}


==Further reading==
==Further reading==
Line 61: Line 17:
{{PBB_Further_reading  
{{PBB_Further_reading  
| citations =  
| citations =  
*{{cite journal | author=Colonna M, Samaridis J |title=Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. |journal=Science |volume=268 |issue= 5209 |pages= 405-8 |year= 1995 |pmid= 7716543 |doi= }}
*{{cite journal   |vauthors=Wagtmann N, Biassoni R, Cantoni C, etal |title=Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains. |journal=Immunity |volume=2 |issue= 5 |pages= 439–49 |year= 1995 |pmid= 7749980 |doi=10.1016/1074-7613(95)90025-X  }}
*{{cite journal | author=Wagtmann N, Biassoni R, Cantoni C, ''et al.'' |title=Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains. |journal=Immunity |volume=2 |issue= 5 |pages= 439-49 |year= 1995 |pmid= 7749980 |doi=  }}
*{{cite journal   |vauthors=Döhring C, Scheidegger D, Samaridis J, etal |title=A human killer inhibitory receptor specific for HLA-A1,2. |journal=J. Immunol. |volume=156 |issue= 9 |pages= 3098–101 |year= 1996 |pmid= 8617928 |doi=  }}
*{{cite journal | author=Döhring C, Scheidegger D, Samaridis J, ''et al.'' |title=A human killer inhibitory receptor specific for HLA-A1,2. |journal=J. Immunol. |volume=156 |issue= 9 |pages= 3098-101 |year= 1996 |pmid= 8617928 |doi= }}
*{{cite journal   |vauthors=Pende D, Biassoni R, Cantoni C, etal |title=The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer. |journal=J. Exp. Med. |volume=184 |issue= 2 |pages= 505–18 |year= 1996 |pmid= 8760804 |doi=10.1084/jem.184.2.505  | pmc=2192700  }}
*{{cite journal  | author=Döhring C, Samaridis J, Colonna M |title=Alternatively spliced forms of human killer inhibitory receptors. |journal=Immunogenetics |volume=44 |issue= 3 |pages= 227-30 |year= 1996 |pmid= 8662091 |doi=  }}
*{{cite journal   |vauthors=Wagtmann N, Rajagopalan S, Winter CC, etal |title=Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer. |journal=Immunity |volume=3 |issue= 6 |pages= 801–9 |year= 1996 |pmid= 8777725 |doi=10.1016/1074-7613(95)90069-1 }}
*{{cite journal | author=Pende D, Biassoni R, Cantoni C, ''et al.'' |title=The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer. |journal=J. Exp. Med. |volume=184 |issue= 2 |pages= 505-18 |year= 1996 |pmid= 8760804 |doi=  }}
*{{cite journal   |vauthors=Uhrberg M, Valiante NM, Shum BP, etal |title=Human diversity in killer cell inhibitory receptor genes. |journal=Immunity |volume=7 |issue= 6 |pages= 753–63 |year= 1998 |pmid= 9430221 |doi=10.1016/S1074-7613(00)80394-5 }}
*{{cite journal | author=Wagtmann N, Rajagopalan S, Winter CC, ''et al.'' |title=Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer. |journal=Immunity |volume=3 |issue= 6 |pages= 801-9 |year= 1996 |pmid= 8777725 |doi=  }}
*{{cite journal   |vauthors=Kwon D, Chwae YJ, Choi IH, etal |title=Diversity of the p70 killer cell inhibitory receptor (KIR3DL) family members in a single individual. |journal=Mol. Cells |volume=10 |issue= 1 |pages= 54–60 |year= 2000 |pmid= 10774747 |doi=10.1007/s10059-000-0054-0 }}
*{{cite journal | author=Uhrberg M, Valiante NM, Shum BP, ''et al.'' |title=Human diversity in killer cell inhibitory receptor genes. |journal=Immunity |volume=7 |issue= 6 |pages= 753-63 |year= 1998 |pmid= 9430221 |doi=  }}
*{{cite journal  |vauthors=Goodier MR, Londei M |title=Lipopolysaccharide stimulates the proliferation of human CD56+CD3- NK cells: a regulatory role of monocytes and IL-10. |journal=J. Immunol. |volume=165 |issue= 1 |pages= 139–47 |year= 2000 |pmid= 10861046 |doi=  10.4049/jimmunol.165.1.139}}
*{{cite journal  | author=Kwon D, Chwae YJ, Choi IH, ''et al.'' |title=Diversity of the p70 killer cell inhibitory receptor (KIR3DL) family members in a single individual. |journal=Mol. Cells |volume=10 |issue= 1 |pages= 54-60 |year= 2000 |pmid= 10774747 |doi=  }}
*{{cite journal   |vauthors=Gardiner CM, Guethlein LA, Shilling HG, etal |title=Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism. |journal=J. Immunol. |volume=166 |issue= 5 |pages= 2992–3001 |year= 2001 |pmid= 11207248 |doi=  10.4049/jimmunol.166.5.2992}}
*{{cite journal | author=Goodier MR, Londei M |title=Lipopolysaccharide stimulates the proliferation of human CD56+CD3- NK cells: a regulatory role of monocytes and IL-10. |journal=J. Immunol. |volume=165 |issue= 1 |pages= 139-47 |year= 2000 |pmid= 10861046 |doi=  }}
*{{cite journal   |vauthors=Shilling HG, Guethlein LA, Cheng NW, etal |title=Allelic polymorphism synergizes with variable gene content to individualize human KIR genotype. |journal=J. Immunol. |volume=168 |issue= 5 |pages= 2307–15 |year= 2002 |pmid= 11859120 |doi=  10.4049/jimmunol.168.5.2307}}
*{{cite journal | author=Gardiner CM, Guethlein LA, Shilling HG, ''et al.'' |title=Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism. |journal=J. Immunol. |volume=166 |issue= 5 |pages= 2992-3001 |year= 2001 |pmid= 11207248 |doi=  }}
*{{cite journal   |vauthors=Strausberg RL, Feingold EA, Grouse LH, etal |title=Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=99 |issue= 26 |pages= 16899–903 |year= 2003 |pmid= 12477932 |doi= 10.1073/pnas.242603899  | pmc=139241 }}
*{{cite journal | author=Shilling HG, Guethlein LA, Cheng NW, ''et al.'' |title=Allelic polymorphism synergizes with variable gene content to individualize human KIR genotype. |journal=J. Immunol. |volume=168 |issue= 5 |pages= 2307-15 |year= 2002 |pmid= 11859120 |doi= }}
*{{cite journal   |vauthors=Chan HW, Kurago ZB, Stewart CA, etal |title=DNA methylation maintains allele-specific KIR gene expression in human natural killer cells. |journal=J. Exp. Med. |volume=197 |issue= 2 |pages= 245–55 |year= 2003 |pmid= 12538663 |doi=10.1084/jem.20021127  | pmc=2193817  }}
*{{cite journal | author=Strausberg RL, Feingold EA, Grouse LH, ''et al.'' |title=Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=99 |issue= 26 |pages= 16899-903 |year= 2003 |pmid= 12477932 |doi= 10.1073/pnas.242603899 }}
*{{cite journal   |vauthors=Becker S, Tonn T, Füssel T, etal |title=Assessment of killer cell immunoglobulinlike receptor expression and corresponding HLA class I phenotypes demonstrates heterogenous KIR expression independent of anticipated HLA class I ligands. |journal=Hum. Immunol. |volume=64 |issue= 2 |pages= 183–93 |year= 2003 |pmid= 12559621 |doi=10.1016/S0198-8859(02)00802-9 }}
*{{cite journal | author=Chan HW, Kurago ZB, Stewart CA, ''et al.'' |title=DNA methylation maintains allele-specific KIR gene expression in human natural killer cells. |journal=J. Exp. Med. |volume=197 |issue= 2 |pages= 245-55 |year= 2003 |pmid= 12538663 |doi=  }}
*{{cite journal   |vauthors=Dorothée G, Echchakir H, Le Maux Chansac B, etal |title=Functional and molecular characterization of a KIR3DL2/p140 expressing tumor-specific cytotoxic T lymphocyte clone infiltrating a human lung carcinoma. |journal=Oncogene |volume=22 |issue= 46 |pages= 7192–8 |year= 2003 |pmid= 14562047 |doi= 10.1038/sj.onc.1206627 }}
*{{cite journal | author=Becker S, Tonn T, Füssel T, ''et al.'' |title=Assessment of killer cell immunoglobulinlike receptor expression and corresponding HLA class I phenotypes demonstrates heterogenous KIR expression independent of anticipated HLA class I ligands. |journal=Hum. Immunol. |volume=64 |issue= 2 |pages= 183-93 |year= 2003 |pmid= 12559621 |doi= }}
*{{cite journal   |vauthors=Artavanis-Tsakonas K, Eleme K, McQueen KL, etal |title=Activation of a subset of human NK cells upon contact with Plasmodium falciparum-infected erythrocytes. |journal=J. Immunol. |volume=171 |issue= 10 |pages= 5396–405 |year= 2004 |pmid= 14607943 |doi= 10.4049/jimmunol.171.10.5396}}
*{{cite journal | author=Dorothée G, Echchakir H, Le Maux Chansac B, ''et al.'' |title=Functional and molecular characterization of a KIR3DL2/p140 expressing tumor-specific cytotoxic T lymphocyte clone infiltrating a human lung carcinoma. |journal=Oncogene |volume=22 |issue= 46 |pages= 7192-8 |year= 2003 |pmid= 14562047 |doi= 10.1038/sj.onc.1206627 }}
*{{cite journal   |vauthors=Meenagh A, Williams F, Sleator C, etal |title=Investigation of killer cell immunoglobulin-like receptor gene diversity V. KIR3DL2. |journal=Tissue Antigens |volume=64 |issue= 3 |pages= 226–34 |year= 2005 |pmid= 15304002 |doi= 10.1111/j.1399-0039.2004.00272.x }}
*{{cite journal | author=Artavanis-Tsakonas K, Eleme K, McQueen KL, ''et al.'' |title=Activation of a subset of human NK cells upon contact with Plasmodium falciparum-infected erythrocytes. |journal=J. Immunol. |volume=171 |issue= 10 |pages= 5396-405 |year= 2004 |pmid= 14607943 |doi= }}
*{{cite journal   |vauthors=Yan LX, Zhu FM, Jiang K, etal |title=Investigation of killer cell immunoglobulin-like receptors gene KIR3DL2 diversity and confirmation of KIR3DL2*015 in a Chinese population. |journal=Tissue Antigens |volume=68 |issue= 3 |pages= 220–4 |year= 2006 |pmid= 16948642 |doi= 10.1111/j.1399-0039.2006.00651.x }}
*{{cite journal | author=Meenagh A, Williams F, Sleator C, ''et al.'' |title=Investigation of killer cell immunoglobulin-like receptor gene diversity V. KIR3DL2. |journal=Tissue Antigens |volume=64 |issue= 3 |pages= 226-34 |year= 2005 |pmid= 15304002 |doi= 10.1111/j.1399-0039.2004.00272.x }}
*{{cite journal  |vauthors=Ortonne N, Bagot M, Bensussan A |title=[KIR3DL2: a new step for the management of patients with Sezary syndrome] |journal=Med Sci (Paris) |volume=22 |issue= 8-9 |pages= 691–3 |year= 2006 |pmid= 16962036 |doi= 10.1051/medsci/20062289691}}
*{{cite journal  | author=Yan LX, Zhu FM, Jiang K, ''et al.'' |title=Investigation of killer cell immunoglobulin-like receptors gene KIR3DL2 diversity and confirmation of KIR3DL2*015 in a Chinese population. |journal=Tissue Antigens |volume=68 |issue= 3 |pages= 220-4 |year= 2006 |pmid= 16948642 |doi= 10.1111/j.1399-0039.2006.00651.x }}
*{{cite journal  |vauthors=Gedil MA, Steiner NK, Hurley CK |title=KIR3DL2: diversity in a hematopoietic stem cell transplant population. |journal=Tissue Antigens |volume=70 |issue= 3 |pages= 228–32 |year= 2007 |pmid= 17661911 |doi= 10.1111/j.1399-0039.2007.00880.x }}
*{{cite journal  | author=Ortonne N, Bagot M, Bensussan A |title=[KIR3DL2: a new step for the management of patients with Sezary syndrome] |journal=Med Sci (Paris) |volume=22 |issue= 8-9 |pages= 691-3 |year= 2006 |pmid= 16962036 |doi=  }}
*{{cite journal  | author=Gedil MA, Steiner NK, Hurley CK |title=KIR3DL2: diversity in a hematopoietic stem cell transplant population. |journal=Tissue Antigens |volume=70 |issue= 3 |pages= 228-32 |year= 2007 |pmid= 17661911 |doi= 10.1111/j.1399-0039.2007.00880.x }}
}}
}}
{{refend}}
{{refend}}


{{membrane-protein-stub}}
{{NLM content}}
{{NLM content}}
{{Clusters of differentiation}}
{{Clusters of differentiation}}
<!-- The PBB_Controls template provides controls for Protein Box Bot, please see Template:PBB_Controls for details. -->
{{PBB_Controls
| update_page = yes
| require_manual_inspection = no
| update_protein_box = yes
| update_summary = no
| update_citations = yes
}}
[[Category:Clusters of differentiation]]
[[Category:Clusters of differentiation]]
{{WikiDoc Sources}}
[[Category:Immunoglobulin superfamily]]
 
 
{{membrane-protein-stub}}
{{immunology-stub}}

Revision as of 06:29, 2 September 2017

VALUE_ERROR (nil)
Identifiers
Aliases
External IDsGeneCards: [1]
Orthologs
SpeciesHumanMouse
Entrez

n/a

n/a

Ensembl

n/a

n/a

UniProt

n/a

n/a

RefSeq (mRNA)

n/a

n/a

RefSeq (protein)

n/a

n/a

Location (UCSC)n/an/a
PubMed searchn/an/a
Wikidata
View/Edit Human

Killer cell immunoglobulin-like receptor 3DL2 is a protein that in humans is encoded by the KIR3DL2 gene.[1][2][3] Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several "framework" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. This gene is one of the "framework" loci that is present on all haplotypes.[3]

See also

References

  1. ↑ Colonna M, Samaridis J (May 1995). "Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells". Science. 268 (5209): 405–8. doi:10.1126/science.7716543. PMID 7716543.
  2. ↑ Dohring C, Samaridis J, Colonna M (Aug 1996). "Alternatively spliced forms of human killer inhibitory receptors". Immunogenetics. 44 (3): 227–30. doi:10.1007/BF02602590. PMID 8662091.
  3. ↑ 3.0 3.1 "Entrez Gene: KIR3DL2 killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2".

Further reading

This article incorporates text from the United States National Library of Medicine, which is in the public domain.


Retrieved from "https://www.wikidoc.org/index.php?title=KIR3DL2&oldid=1418865"